Risk stratification of men with clinically localized prostate cancer has historically relied on
basic clinicopathologic parameters such as prostate specific antigen level, grade group, and …

Localized prostate cancer (PCa) is a clinically heterogeneous disease, which presents with
variability in patient outcomes within the same risk stratification (low, intermediate or high) …

Prostate cancer exhibits intra-tumoral heterogeneity that we hypothesize to be the leading
confounding factor contributing to the underperformance of the current pre-treatment clinical …

Background. The Operations Research Interest Group (ORIG) within the Society of Medical
Decision Making (SMDM) is a multidisciplinary interest group of professionals that …

Background Controversy exists regarding the effectiveness of early adjuvant versus salvage
radiation therapy after prostatectomy for prostate cancer. Estimates of prostate cancer …

Introduction: Prostate cancer is a heterogeneous disease. Existing risk stratification tools
based on standard clinlicopathologic variables (prostate specific antigen [PSA], Gleason …

Background: To date, there have been no published trials examining the impact of salvage
radiation therapy (SRT) in the post-operative setting for prostate cancer (PCa). We …

Aim: We developed a decision analysis framework to simulate the clinical choice of early
adjuvant versus delayed salvage radiation therapy after radical prostatectomy. Materials & …

There is an increase in the use of prognostic gene expression biomarkers in the USA for the
personalisation of treatment for men with localised and recurrent prostate cancer. However …

EXCLUDED STUDIES - Prognostic Value of Genomic Classifier Testing for Prostate Cancer: A
Systematic Review - NCBI Bookshelf US flag An official website of the United States government …